(Q43535238)

24 November 2017

title

Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia (English)

1 reference

24 November 2017

0 references

Stip E

1

1 reference

24 November 2017

Caron J

2

1 reference

24 November 2017

Renaud S

3

1 reference

24 November 2017

Pampoulova T

4

1 reference

24 November 2017

Lecomte Y

5

1 reference

24 November 2017

publication date

1 July 2003

1 reference

24 November 2017

published in

Comprehensive Psychiatry

1 reference

24 November 2017

volume

44

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

331-340

1 reference

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Memory and attention deficits in drug naive patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Memory in schizophrenia: what is impaired and what is preserved?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

The heterogeneity of memory dysfunction in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Neuropsychological function in schizophrenia. Selective impairment in memory and learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

What are the functional consequences of neurocognitive deficits in schizophrenia?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

The subjective experience of deficits in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Abnormal subjective experiences in schizophrenia: its relationships with neuropsychological disturbances and frontal signs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Schneiderian versus Bleulerian Schizophrenia and Basic Symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Positive versus negative schizophrenia and basic symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

The measurement of subjective experience in schizophrenia: the Subjective Deficit Syndrome Scale.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

The subjective experience of negative symptoms: a self-rating scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Cognitive dysfunction at baseline predicts symptomatic 1-year outcome in first-episode schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Schizophrenia-specific basic symptoms. A successful replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Factor analysis of the Frankfurt Complaint Questionnaire in a Spanish sample.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Diagnosing schizophrenia in the initial prodromal phase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Basic symptoms and their contribution to the differential typology of acute schizophrenic and schizoaffective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

The positive and negative syndrome scale (PANSS) for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Specificity of the Calgary Depression Scale for schizophrenics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Visual hemispatial inattention: stimulus parameters and exploratory strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Coefficient alpha and the internal structure of tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

"General Intelligence," Objectively Determined and Measured

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Rotation for simple loadings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Concurrent validity of the cognitive component of schizophrenia: relationship of PANSS scores to neuropsychological assessments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Components of social support and quality of life in severely mentally ill, low income individuals and a general population group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Patients' requests and satisfaction with services in an outpatient psychiatric setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Relationships between subjective experiences of deficit and other psychopathological features in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Memory complaint in a community sample aged 70 and older.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Psychopathologic domains and insight in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Insight and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Insight Into Illness in Schizophrenia, Schizoaffective Disorder, and Mood Disorders With Psychotic Features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

Backward masking performance as an indicator of vulnerability to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Assessment of the patient's subjective experience in acute neuroleptic treatment: implications for compliance and outcome.

1 reference

https://api.crossref.org/works/10.1016/S0010-440X(03)50086-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0010-440X(03)00086-5

1 reference

24 November 2017

1 reference